C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor

Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629)
08/2002
08/01/2002	WO2002059286A2 Adenylate cyclases
08/01/2002	WO2002059285A1 Methods for immortalizing cells
08/01/2002	WO2002059283A2 Nucleic acid modification enzymes
08/01/2002	WO2002059282A2 Adipocyte complement related protein zacrp13
08/01/2002	WO2002059281A2 High level cytokine production with enhanced cell viability
08/01/2002	WO2002059280A2 Chronic lymphocytic leukemia cell line and its use for producing an antibody
08/01/2002	WO2002059279A2 Preparation of replicating kupffer cells and their use in diagnosis and therapy
08/01/2002	WO2002059278A2 Differentiation of stem cells to pancreatic endocrine cells
08/01/2002	WO2002059277A2 Electroactive materials for stimulation of biological activity of stem cells
08/01/2002	WO2002059276A2 Culture medium
08/01/2002	WO2002059267A2 Constitutively desensitized g protein-coupled receptors
08/01/2002	WO2002059266A2 Dna encoding human alpha and beta subunits of neuronal nicotinic acetylcholine receptor
08/01/2002	WO2002059263A2 Transgenic animals comprising a humanized immune system
08/01/2002	WO2002059256A2 Sequences involved in phenomena of tumour suppression, tumour reversion, apoptosis and/or virus resistance and their use as medicines
08/01/2002	WO2002059248A2 A novel gene associated with regulation of adiposity and insulin response
08/01/2002	WO2002059154A2 Neutralizing human monoclonal antibodies against hiv-1, their production and uses
08/01/2002	WO2002059153A2 Anticoagulants and their uses
08/01/2002	WO2002059150A2 Materials and methods relating to protein aggregation in neurodegenerative disease
08/01/2002	WO2002059140A2 Ikaros rgulatory elements and uses thereof
08/01/2002	WO2002058716A2 Treatment of inflammatory bowel disease using growth factors
08/01/2002	WO2002058588A2 Processes for making cryopreserved composite living constructs and products resulting therefrom
08/01/2002	WO2002058546A2 Methods for screening for substances which inhibit fp prostanoid receptor
08/01/2002	WO2002058532A2 Method for identifying ligands to lxr-receptor that stimulates pre-adipocyte differentiation and formulations thereof
08/01/2002	WO2002043651A3 Methods of utilizing cultured non-gvhd inducing t lymphocytes to treat disease
08/01/2002	WO2002042480A3 Modified vaccinia ankara virus variant
08/01/2002	WO2002036761A9 Compositions and methods for the diagnosis of cancer
08/01/2002	WO2002031157A3 Shrimp alkaline phosphatase
08/01/2002	WO2002020614A3 Endoglin-specific polypeptide, production and use thereof
08/01/2002	WO2002016620A3 Modulation of stem cell differentiation
08/01/2002	WO2002014480A3 Decellularized tissue engineered constructs and tissues
08/01/2002	WO2002014466A3 Pth analogs for renal osteodystrophy and related uses
08/01/2002	WO2002008285A3 Il-17 molecules and uses thereof
08/01/2002	WO2002004509A3 Gene expression, genome alteration and reporter expression in myofibroblasts and myofibroblast-like cells
08/01/2002	WO2002002625A3 Novel fibroblast growth factors and nucleic acids encoding same
08/01/2002	WO2001096565A3 Binding agents: chimeric ligand/receptor proteins
08/01/2002	WO2001094552A3 Mammalian gamete and embryo culture media supplement and method of using same
08/01/2002	WO2001092551A3 Duplexed parvovirus vectors
08/01/2002	WO2001090315A3 Production of neurons from stem cells
08/01/2002	WO2001072836A3 G-protein coupled receptors
08/01/2002	WO2001045492A3 Protein kinase stress-related proteins and methods of use in plants
08/01/2002	WO2001026678A9 Short segments of dap-kinase
08/01/2002	WO2000077040A9 Human intracellular signaling molecules
08/01/2002	US20020104128 Methods for generating doubled haploid plants
08/01/2002	US20020104127 Genetically engineered plant cells for use in the generation of heterlogous proteins
08/01/2002	US20020104123 Viral amplification of recombinant messenger RNA in transgenic plants
08/01/2002	US20020104120 Transgenic plants carrying neoxanthin cleavage enzyme gene
08/01/2002	US20020104117 Nucleotide sequence coding for use as tools in the generation of disease and herbicide resistant plants
08/01/2002	US20020104113 Nav2 channel gene-deficient non-human animals
08/01/2002	US20020104112 Ikaros regulatory elements and uses thereof
08/01/2002	US20020104111 ACC2-Knockout mice and uses thereof
08/01/2002	US20020104110 Immunologically privileged cells and uses thereof
08/01/2002	US20020104109 Transgenic animals
08/01/2002	US20020104108 Expression vector coding polypeptides for use in the treatment of alzheimer's dieases and tumors
08/01/2002	US20020103475 Implantable bioartificial active sercretion system
08/01/2002	US20020103363 Promoter derived from phytosulfokine precursor gene
08/01/2002	US20020103342 Polypeptide for use in the diagnosis, prevention, and treatment of developmental, reproductive, immunological, and tumor disorders
08/01/2002	US20020103340 Rab proteins
08/01/2002	US20020103337 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof
08/01/2002	US20020103336 Cloning of chicken anemia dna
08/01/2002	US20020103222 Oxygenating storage media by adding oxygen, carbon dioxide, and pure emulsified perfluorocarbons; for transplant organs (especially corneas)
08/01/2002	US20020103148 Vectors comprising SAR elements
08/01/2002	US20020103125 Secreted and transmembrane polypeptides and nucleic acids encoding the same
08/01/2002	US20020103123 Administering coumpounds such as aromatic alkyl diamine derivatives as Y5 receptor agonist or antagonist to increase or decrease food consumption
08/01/2002	US20020103121 Amino acid sequence of residues 163-199 used to induce apoptosis in a cell
08/01/2002	US20020103115 Useful in the development of human therapeutics and diagnostic compositions and methods
08/01/2002	US20020103111 Comprising peptide sequences which mimic the conserved amino acid motif LDTSL of MAdCAM-1 and which have groups bonded to the N- and C- termini; treatment of inflammatory bowel disease
08/01/2002	US20020102733 Drug delivery system; obtain receptive binding particles, incubate with surface and hydrophilic polymer, incubate with release agent, monitor distribution through biological systems
08/01/2002	US20020102732 Packaging systems for human recombinant adenovirus to be used in gene therapy
08/01/2002	US20020102730 Expression system for factor VIII
08/01/2002	US20020102727 Methods and compositions for organ decellularization
08/01/2002	US20020102726 Which forms a reconstructed epidermis, used to test various factors on human skin equivalent, such as drugs, cosmetics, surfactants and detergents
08/01/2002	US20020102723 Nucleotide sequences coding polypeptide for use in diagnosis and treatment of pancreatic defects
08/01/2002	US20020102714 Methods using cre-lox for production of recombinant adeno-associated viruses
08/01/2002	US20020102712 Nucleotide sequences coding enzymatic polypeptide for use in the treatment of viral diseases
08/01/2002	US20020102711 Polypeptide for use in the treatment of cancer and immunological
08/01/2002	US20020102707 Nucleotide sequences coding polypeptide for use in the treatment of sexual disorders
08/01/2002	US20020102701 licD1
08/01/2002	US20020102691 Enzymatic polypeptide for use in treatment and prevention of, heart liver and inflammatory disorders
08/01/2002	US20020102690 Genes involved in isoprenoid compound production
08/01/2002	US20020102684 Human phospholipase inhibitor
08/01/2002	US20020102676 Nucleotide sequences coding membrane proteins for use in cancer therapy
08/01/2002	US20020102674 Porous structure for use in generation of control release membranes
08/01/2002	US20020102658 Human monoclonal antibody against a costimulatory signal transduction molecule AILIM and pharmaceutical use thereof
08/01/2002	US20020102657 Binding protein for use as therapeutic tool in the prevention of Infections disease
08/01/2002	US20020102651 Novel B7-4 molecules and uses therefor
08/01/2002	US20020102650 Generating preferential heterologous protein in culture; obtain cells, transform with expression vector containing heterologous protein, recover transformed cells, propagate, culture, express and recover heterologous proteins
08/01/2002	US20020102649 Human transport protein homologs
08/01/2002	US20020102647 Nucleotide sequences coding membrane protein for use in treatment of nervous system disorders and arthritis
08/01/2002	US20020102645 Novel member of the lysyl oxidase gene family
08/01/2002	US20020102643 Dorsal tissue affecting factor and compositions
08/01/2002	US20020102642 Nuclelotide sequences coding preferential protein for use in therapeutic, diagnostic and medical imaging
08/01/2002	US20020102640 Nucleotide sequences coding preferential protein for use in the diagnosis, prevention and treatment of cancer
08/01/2002	US20020102638 Nucleotide sequences coding polypeptide for use in the treatment of viral diseases, genetic disorders and cancer
08/01/2002	US20020102620 Immunoglobulins for use in the diagnosis and detection parasites
08/01/2002	US20020102618 Drosophila derived receptors of the steroid receptor superfamily
08/01/2002	US20020102604 Full-length human cDNAs encoding potentially secreted proteins
08/01/2002	US20020102603 Compositions and methods for the treatment and diagnosis of cardiovascular disease
08/01/2002	US20020102569 Nucleotide sequences for use in the detection, classificataions, treatment and evaluation of cancer therapies
08/01/2002	US20020102566 Identification of neural defects associated with the nucleosomal assembly protein 112 gene
08/01/2002	US20020102560 Nucleotide sequences coding enzymatic polypeptide for use in treatment metastasis and tumors

1 ... 1313 1314 1315 1316 1317 1318 1319 1320 1321 1322 1323 1324 1325 1326 1327 1328 1329 1330 1331 1332 1333 ... 1827